Health News


A new study suggests that teens engaging in the use of electronic cigarettes, or e-cigarettes, are more likely to try the real thing. The study, published online in the journal Pediatrics, included nearly 2,100 California high school students and found that one-quarter had ever "vaped" (tried e-cigarettes). Ten percent of the teens were currently using e-cigarettes.
A new study shows that men gain an average of nearly five pounds after having kids. The study, published in the American Journal of Men's Health, finds that new dads gain an average of about 4.4 pounds after having kids. The study kept track of weight changes among more than 10,000 men over 20 years. In comparison, the average man of the same height without kids actually lost 1.4 pounds. Those in the funeral industry who frequently use formaldehyde in embalming fluid may be at an increased risk of developing ALS, according to a new study from researchers at the Harvard University's T.H. Chan School of Public Health, in Boston. The study focused specifically on male funeral directors. Having weight loss surgery may be more effective in reducing type 2 Diabetes symptoms than lifestyle changes, according to a new study from researchers at University of Pittsburgh Medical Center. For the study the researchers collected data from 61 type 2 diabetes patients between the ages of 25 and 55. Each of the study participants was assigned one of three treatments. More
BrainPic-072215.jpg A new series of studies suggests that women's brains may be more vulnerable to contracting Alzheimer's disease than men. The studies were presented at the Alzheimer's Association International Conference in Washington, D.C. Another study suggests that women's daily activities and cognitive abilities decline faster than men's after undergoing surgery with general anesthesia. Contrary to popular belief, a new study reveals that most women do not regret having an abortion. Researchers looked at 667 women who had abortions between 2008 and 2010 at 30 U.S. clinics. The participants answered questions about their experiences every six months for three years after the procedure. The FDA has offered their approval to a new blood test designed specifically to detect herpes. The new test uses a blood sample collected via a finger prick and was developed by the Silicon Valley-based firm Theranos. The approval is a key step for the drug, which will also benefit from a new law passed in some states allowing for direct-to-consumer tests using finger pricks. More

FDA Approves Metastatic Lung Cancer Treatment

The FDA has offered their approval on a new first-line treatment for metastatic lung cancer patients. The drug, called Iressa (gefitinib), is a kinase inhibitor that prevents the development of proteins that contribute to the creation of cancerous cells. The drug is specifically geared towards patients with a specific epidermal growth factor receptor (EGFR).

Blood Pressure Meds May Cure Addiction

Medication commonly used to treat blood pressure could actually help to cure addiction, according to a new study. According to the study, published in the journal Molecular Psychiatry, the treatment could help ward off relapses by erasing memories in the subconscious that trigger addiction. The experimental drug has already been approved by the U.S. Food and Drug Administration (FDA).

PTSD May Raise Heart Attack And Stroke Risk In Women

The effects of post-traumatic stress disorder, or PTSD, may increase chances of heart attack and stroke in women, according to a new study. Researchers looked at nearly 55,000 women in the Nurses' Health Study II, a long-term study of young women that began in 1989. In 2008, the researchers asked the women to fill out surveys about traumatic events they had experienced in the last 20 years.
Fiat Chrysler Automobiles (FCAU) on Friday has recalled about 1.4 million vehicles equipped with certain radios to update software after researchers were able to remotely hack into a Jeep. The company is already distributing software that insulates connected vehicles from remote manipulation, which,... More

Follow RTT
FDA Calendar
Event DateSymbolDrug NameEvent Name
10/27/2015AMGNTalimogene laherparepvec (NDA)FDA decision on Talimogene laherparepvec for advanced melanoma
10/24/2015MACKMM-398 (NDA) FDA decision on MM-398 for the treatment of patients with metastatic adenocarcinoma of the pancreas who have been previously treated with gemcitabine-based therapy
10/21/2015RLYPPatiromer for Oral Suspension (NDA) FDA decision on Patiromer for the treatment of hyperkalemia
10/02/2015MRKKeytruda (sBLA)FDA decision on Keytruda for the treatment of patients with advanced non-small cell lung cancer
09/08/2015GEVAKanuma (BLA)FDA decision on Kanuma for the treatment of lysosomal acid lipase deficiency
09/05/2015TSROOral Rolapitant (NDA)FDA decision on oral Rolapitant for the prevention of chemotherapy-induced nausea and vomiting
More FDA Calendar Data

FDA Device Approval
No Records Found
More FDA Device Approval Data